Drug Profile
NWP 08
Alternative Names: NWP08Latest Information Update: 01 Oct 2018
Price :
$50
*
At a glance
- Originator NextWave Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 25 Sep 2018 NextWave Pharmaceuticals has been acquired by Tris Pharma
- 28 Nov 2012 NextWave Pharmaceuticals has been acquired by Pfizer